5-MAPDI

5-MAPDI is an entactogenic amphetamine derivative which is structurally related to MDMA as well as to dihydrobenzofuran derivatives such as 5-MAPDB and 6-MAPDB, and has been sold as a designer drug. It has reportedly been sold over grey-market websites since around 2014, although the first definitive identification was not made until September 2016 by a forensic laboratory in Slovenia.

Classification

Chemical: Benzofuran
Chemical: Phenethylamine
Psychoactive: Entactogen

Effects

Stimulation
Insomnia
Increased Heart Rate
Nausea
Pupil Dilation
Bruxism
Euphoria
Anxiety
Talkativeness
Alertness Enhancement
Mood Lift
Anxiety Suppression
Light Sensitivity
Sexual Dysfunction
Tactile Enhancement
Music Appreciation
Visual Acuity Enhancement
Increased Music Appreciation

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu